Home » Authors » James Etheridge

Articles by James Etheridge

Sanofi-Synthélabo Selects Melanoma Vaccine From IDM

Feb. 20, 2002

By James Etheridge

Transgene Says Restructuring In Place, Products Moving Along

Feb. 13, 2002

By James Etheridge

Transgene Says Restructuring In Place, Products Moving Along

Feb. 13, 2002

By James Etheridge

France Biotech Wants Initiatives To Assist Industry Across EU

Feb. 6, 2002

By James Etheridge

Hybrigenics, Mindsense Align To Advance Work In Depression

Feb. 6, 2002

By James Etheridge

Cerep Extends Drug Discovery Deal With Sanofi-Synth labo

Feb. 6, 2002

By James Etheridge

Cerep Extends Drug Discovery Deal With Sanofi-Synth labo

Feb. 6, 2002

By James Etheridge

Hybrigenics, Mindsense Align To Advance Work In Depression

Feb. 6, 2002

By James Etheridge

France Biotech Wants Initiatives To Assist Industry Across EU

Feb. 6, 2002

By James Etheridge

Galapagos, Exelixis Collaborate To Analyze Functions Of Genes

Jan. 30, 2002

By James Etheridge

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 17, 2025
Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal
BioWorld
The J.P. Morgan (JPM) Healthcare Conference in San Francisco kicked off with a resounding bang as Johnson & Johnson (J&J) disclosed plans to acquire...
Proteomics study explores how protein changes influence disease
BioWorld Science
Fourteen global pharma companies are getting together to conduct the largest proteomics study to date, analyzing 600,000 blood samples held in the UK Biobank to...
Abbvie and Simcere enter a $1B T-cell engager deal
BioWorld Asia
Abbvie Inc. and Simcere Zaiming Pharmaceutical Co. Ltd. are part of the volley of large deals accompanying the opening of the 43rd annual J.P. Morgan Healthcare...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.